Kojin Therapeutics
Boston, United States · $60.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $60.0M Series AJun 2021
- Rounds
- 1
About
Biopharmaceutical company developing novel therapeutics based on ferroptosis and cell state biology.
Summary
Kojin Therapeutics is a Biotech company based in Boston, United States. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Jun 2021. Investors include Polaris Partners, Newpath Management and Cathay Capital.
Funding History
Jun 2021
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kojin-therapeutics"><img src="https://indexed.vc/api/badge/company/kojin-therapeutics" alt="Kojin Therapeutics on Indexed.vc" width="260" height="76" /></a>